← Back to Screener
Tenaya Therapeutics, Inc. Common Stock (TNYA)
Price$0.73
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-55.92%
Price vs S&P 500 (4W)-27.18%
VGM Score58.29
Market Capitalization$158.00M
All Metrics
Book Value / Share (Quarterly)$0.49
P/TBV (Annual)0.51x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.30
Price vs S&P 500 (YTD)-5.90%
EPS (TTM)$-0.47
10-Day Avg Trading Volume3.77M
EPS Excl Extra (TTM)$-0.47
EPS (Annual)$-0.59
ROI (Annual)-73.50%
Cash / Share (Quarterly)$0.37
ROA (Last FY)-61.66%
EBITD / Share (TTM)$-0.44
ROE (5Y Avg)-71.82%
Cash Flow / Share (Annual)$-0.32
P/B Ratio1.49x
P/B Ratio (Quarterly)1.41x
Net Income / Employee (Annual)$-1,294,200
ROA (TTM)-65.21%
EPS Incl Extra (Annual)$-0.59
Current Ratio (Annual)6.84x
Quick Ratio (Quarterly)5.45x
3-Month Avg Trading Volume4.54M
52-Week Price Return34.83%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$2.42
52-Week High$2.35
EPS Excl Extra (Annual)$-0.59
CapEx CAGR (5Y)-42.42%
26-Week Price Return-47.99%
Quick Ratio (Annual)6.58x
13-Week Price Return-11.10%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)5.75x
Enterprise Value$77.11M
Revenue / Employee (Annual)$0
Cash / Share (Annual)$0.46
3-Month Return Std Dev118.86%
Net Income / Employee (TTM)$-1,185,800
ROE (Last FY)-73.50%
EPS Basic Excl Extra (Annual)$-0.59
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-0.47
ROI (TTM)-80.56%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$3.64
Price vs S&P 500 (52W)10.47%
Year-to-Date Return2.26%
5-Day Price Return-16.31%
EPS Normalized (Annual)$-0.59
ROA (5Y Avg)-58.91%
Month-to-Date Return-16.21%
Cash Flow / Share (TTM)$-1.73
EBITD / Share (Annual)$-0.56
ROI (5Y Avg)-71.82%
EPS Basic Excl Extra (TTM)$-0.47
P/TBV (Quarterly)0.76x
P/B Ratio (Annual)1.25x
Book Value / Share (Annual)$0.57
Price vs S&P 500 (13W)-19.35%
Beta2.90x
Revenue / Share (TTM)$0.00
ROE (TTM)-80.56%
52-Week Low$0.52
mGradeC
vgmGradeC
Show chart for
Earnings Surprise History
Q1 26-0.09est. -0.09
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
4.21
4.21
4.21
4.21
Industry Peers — Biological Products(178)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
TNYATenaya Therapeutics, Inc. Common Stock | — | — | C | $0.73 |
| AMGNAmgen Inc | C | C | C | $349.58 |
| GILDGilead Sciences Inc | C | B | C | $129.16 |
| ARGXargenx SE American Depositary Shares | D | A | B | $891.32 |
| RVMDRevolution Medicines, Inc. Common Stock | F | — | A | $149.23 |
| BIIBBiogen Inc. Common Stock | B | D | B | $195.34 |
| BNTXBioNTech SE American Depositary Share | C | C | D | $88.08 |
| MRNAModerna, Inc. Common Stock | C | B | B | $47.44 |
| NBIXNeurocrine Biosciences Inc | C | B | B | $163.88 |
| EXELExelixis Inc | C | B | B | $52.70 |
| KRYSKrystal Biotech, Inc. Common Stock | D | B | A | $301.00 |
About
Tenaya Therapeutics is a preclinical-stage biotech company developing curative therapies for heart disease across three platforms: gene therapy, cellular regeneration, and precision medicine. The company targets the root causes of cardiac disease, aiming to deliver transformative treatments addressing significant unmet medical needs.